Genprex, Inc. (GNPX)
2.84
-0.09
(-3.07%)
USD |
NASDAQ |
Jan 23, 16:00
2.85
+0.01
(+0.35%)
After-Hours: 20:00
Genprex Research and Development Expense (TTM): 10.07M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Arvinas, Inc. | 306.40M |
| Olema Pharmaceuticals, Inc. | 146.78M |
| NovaBay Pharmaceuticals, Inc. | -- |
| Palatin Technologies, Inc. | 11.68M |
| Theriva Biologics, Inc. | 10.36M |